Advertisement

Topics

Generon Presented Pre-Clinical Immunotherapy Results With CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format

22:46 EST 4 Dec 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
A-319 and A-329 immunotherapies may prove beneficial in patients with B cell malignancies with less frequent dosing and lower cytokine inductions December 3rd, 2018, Shanghai, Generon BioMed Holding Ltd (Generon), ann...

Other Sources for this Article

Chris Bosworth
hr@generonbiomed.com,
or visit http://www.generonbiomed.com

NEXT ARTICLE

More From BioPortfolio on "Generon Presented Pre-Clinical Immunotherapy Results With CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cytokine
Cytokines include chemokines, lymphokines, and monokines. Cells of the immune system communicate with one another by releasing and responding to chemical messengers called cytokines. These proteins are secreted by immune cells and act on other cells to...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...